Biotech News – Vivoxid and Hormos (Finland)
Vivoxid, Finland, has entered into two new callaborative agreements with Swedish companies. Vivoxid, who develop and manufacture products for tissue repair and regeneration, have signed a letter of intent with Entific Medical Systems (Sweden) to exploit Vivoxids surface modification technology in Entific’s bone anchored hearing devices. Read the full press release here.
Vivoxid have also signed a option agreement with Osspol (Sweden) to use the same technology in Osspol’s dental implants.Read the full press release here.
Hormos Medical Corporation (Finland) has announced a merger with US based QuatRx Pharmaceuticals. Under the terms of the transaction, Hormos will become a wholly-owned subsidiary of QuatRx. The merger with Hormos will immediately add two clinical-stage compounds to the QuatRx pipeline. Major investors from Hormos will also make an additional investment in QuatRx as an extension of a recent round of venture financing in QuatRx. Read the full press release here.
News Source: Riikka Erkko, ScanBalt Webeditor, Finland.
ScanBalt News
17 April 2024
COBIOE project consortium opens an interconnection platform for the European biomanufacturing sector
12 March 2024
19th National Conference on Health Economy 2024 | 30-31 May 2024 | Mecklenburg-Vorpommern, Germany